Market Value1,663,412,000
Total Holdings64
File Date2021-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CALA / Calithera Biosciences, Inc. Put
OBSV / ObsEva SA.
PBYI / Puma Biotechnology, Inc.
GWP / GW Pharmaceuticals plc
MRUS / Merus N.V.
JNCE / Jounce Therapeutics Inc
KDMN / Kadmon Holdings Inc
LLY / Eli Lilly and Company
OTIC / Otonomy Inc
Nextcure, Inc / COMM (00653E112)
Nucana Biomed Ltd / Ordinary Shares (GBOOBYWYV)
Protagonist Therapeutics Inc / COMM (00744E106)
IGMS / IGM Biosciences, Inc.
ZGNX / Zogenix Inc
MGNX / MacroGenics, Inc.
AMGN / Amgen Inc.
XLB / The Select Sector SPDR Trust - State Street Materials Select Sector SPDR ETF Put
ALGS / Aligos Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
QURE / uniQure N.V.
MRNS / Marinus Pharmaceuticals, Inc.
BCAB / BioAtla, Inc.
BMRN / BioMarin Pharmaceutical Inc.
EXEL / Exelixis, Inc.
REPL / Replimune Group, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
ASND / Ascendis Pharma A/S
SRPT / Sarepta Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
SNDX / Syndax Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
ARNA / Arena Pharmaceuticals Inc
LQDA / Liquidia Corporation
APTO / Aptose Biosciences Inc.
ATHA / LeonaBio, Inc.
CYTK / Cytokinetics, Incorporated
IOVA / Iovance Biotherapeutics, Inc. Put
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc.
AKUS / Akouos Inc
XLV / The Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF Put
FATE / Fate Therapeutics, Inc.
CMPI / Checkmate Pharmaceuticals Inc
14161H108 / Cardtronics PLC
CALA / Calithera Biosciences, Inc.
CALA / Calithera Biosciences, Inc. Call
HZNP / Horizon Therapeutics Plc
CCXI / Churchill Capital Corp XI Put
CCXI / Churchill Capital Corp XI
ITCI / Intra-Cellular Therapies, Inc.
DXCM / DexCom, Inc.
HRTX / Heron Therapeutics, Inc. Call
ACAD / ACADIA Pharmaceuticals Inc.
INSM / Insmed Incorporated
MIRM / Mirum Pharmaceuticals, Inc.
JAZZ / Jazz Pharmaceuticals plc
CHRS / Coherus Oncology, Inc.
RCUS / Arcus Biosciences, Inc.
PODD / Insulet Corporation
ABBV / AbbVie Inc.
KRTX / Karuna Therapeutics, Inc.
ALGN / Align Technology, Inc.
RGNX / REGENXBIO Inc.
MRTX / Mirati Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
PTCT / PTC Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
VRTX / Vertex Pharmaceuticals Incorporated
GRTX / Galera Therapeutics, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
SVRA / Savara Inc.
GILD / Gilead Sciences, Inc. Call
UTHR / United Therapeutics Corporation
NTRA / Natera, Inc.
SYBX / Synlogic, Inc.
TGTX / TG Therapeutics, Inc.
AGEN / Agenus Inc.
IMTX / Immatics N.V.
PDSB / PDS Biotechnology Corporation
KURA / Kura Oncology, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
NXTC / NextCure, Inc.
YMAB / Y-mAbs Therapeutics, Inc.